The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. GeneDx Holdings Corp shares valued at $452,850 were sold by Feeley Kevin on Sep 16 ’25. At $121.47 per share, Feeley Kevin sold 3,728 shares. The insider’s holdings dropped to 8,755 shares worth approximately $1.0 million following the completion of this transaction.
Also, Stueland Katherine sold 10,501 shares, netting a total of over 1,275,585 in proceeds. Following the sale of shares at $121.47 each, the insider now holds 14,578 shares.
Before that, Stueland Katherine had sold 3,657 shares from its account. In a trade valued at $468,297, the Chief Executive Officer traded GeneDx Holdings Corp shares for $128.06 each. Upon closing the transaction, the insider’s holdings decreased to 3,657 shares, worth approximately $0.72 million.
As published in their initiating research note from Piper Sandler on July 09, 2025, GeneDx Holdings Corp [WGS] has been an Overweight and the price target has been revised to $110. Analysts at Guggenheim started covering the stock with ‘”a Buy”‘ outlook in a report released in mid May. As of May 09, 2025, Jefferies has increased its “Hold” rating to a “Buy” for WGS. Earlier on August 28, 2024, Wells Fargo initiated its rating. Their recommendation was “an Equal weight” for WGS stock.
Analyzing WGS Stock Performance
On last trading session, GeneDx Holdings Corp [NASDAQ: WGS] plunged -5.97% to $114.22. The stock’s lowest price that day was $113.1, but it reached a high of $121.99 in the same session. During the last five days, there has been a drop of approximately -10.71%. Over the course of the year, GeneDx Holdings Corp shares have jumped approximately 182.72%. Shares of the company reached a 52-week high of $136.00 on 09/08/25 and a 52-week low of $55.17 on 05/08/25.
Support And Resistance Levels for GeneDx Holdings Corp (WGS)
According to the 24-hour chart, there is a support level at 110.88, which, if violated, would cause prices to drop to 107.55. In the upper region, resistance lies at 119.77. The next price resistance is at 125.33. RSI (Relative Strength Index) is 40.61 on the 14-day chart, showing neutral technical sentiment.
Is GeneDx Holdings Corp subject to short interest?
Stocks of GeneDx Holdings Corp saw a sharp steep in short interest on 2025-08-29 dropping by 6176.0 shares to 3.63 million. Data from Yahoo Finance shows that the short interest on 2025-07-31 was 3.64 million shares. A decline of -0.17% in short interest reflects a positive sentiment towards the stock. Despite the fact that short shares comprise just 3.84 of the overall float, the days-to-cover ratio (short ratio) decline to 3.84.
Which companies own the most shares of GeneDx Holdings Corp (WGS)?
In terms of GeneDx Holdings Corp share price expectations, FactSet research, analysts set an average price target of 120 in the next 12 months, down nearly -1.21% from the previous closing price of $121.47. Analysts anticipate GeneDx Holdings Corp stock to reach 120 by 2025, with the lowest price target being 120. In spite of this, 3 analysts ranked GeneDx Holdings Corp stock as Buy at the end of 2025. On July 10, 2024, Craig Hallum assigned a price target of “a Buy” to the stock and initiated coverage with a $43.
